GlassScriptPhysician profile
Jonathan Jeah Seun
NPI 1043072358
$2,946.47
in general payments reported to CMS, 2019-2025
13 companies · $1,134 in 2025
The $1,134 reported for 2025 was more than what 82% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,200 · 2023: $42.03 · 2024: $570 · 2025: $1,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,746.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $1,218.29 | 2022-2023 | |
| Stryker Corporation | $490.66 | 2023-2025 | Prostep, Ortholoc 2 Lapifuse, Spy-Phi System |
| Smith+Nephew, INC. | $231.79 | 2024-2025 | Collagenase Santyl, Stravix, Grafix |
| Lifenet Health | $200.42 | 2025 | Allograft Vmis Delivery System, Pliafx Flo |
| Alafair Biosciences, INC. | $177.25 | 2024 | Versawrap |
| Depuy Synthes Sales INC. | $142.67 | 2025 | Motoband, Hammerlock |
| Amgen INC. | $125.00 | 2025 | Krystexxa |
| Curonix LLC | $110.70 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Paragon 28, INC. | $99.72 | 2024 | Bun-Yo-Matic |
| Paratek Pharmaceuticals, INC. | $64.63 | 2025 | Nuzyra |
| Pacira Pharmaceuticals Incorporated | $41.79 | 2025 | Exparel |
| Ani Pharmaceuticals, INC. | $29.35 | 2025 | Purified Cortrophin Gel |
| Orthofix Medical, INC. | $14.20 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Seun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.